Intriguingly, we observed a significantly lower expression of hepatic Lmo4 after blocking M3R by Olanzapine in female rats, which resulted in weight gain, obesity, and lipid metabolic dysfunction. This evidence concerns the gene LMO4 and obesity due to melanocortin 4 receptor deficiency.